Abstract
purpose. To determine why variations in intraocular pressure (IOP) occur in cultured human anterior segments despite a constant rate of infusion of culture medium. Two types of variations occur: an initial elevation of IOP and small changes in baseline IOP.
methods. Anterior segments from human eyes were placed in perfusion organ culture. In cultures with initially high IOP, eyes were fixed at the high IOP level and histologic examination performed. In other cultures with high initial IOP, effluent medium was collected and subsequently reinfused after IOP had decreased to baseline. In cultures with stable baseline IOP, cell fragments from monolayer-cultured cells, or human genomic DNA, were infused at concentrations equivalent to 30,000 to 300,000 cells.
results. Electron microscopy of initially high-pressure cultures revealed scattered cell debris throughout the meshwork in greater amounts than found in eyes without initially high IOP. Reinfusion of effluent media from cultures with high initial pressures caused elevation of IOP. Centrifugation of effluent media lessened this elevation of IOP. In cultures with stable baseline IOP, infusion of cell fragments or genomic DNA raised IOP in a dose-dependent manner, with elevation of IOP for a minimum of 24 hours.
conclusions. Cell debris can elevate IOP during the initial culture period, and after baseline pressures are established. Cell fragments and DNA increase IOP in a dose-dependent manner. The variations in baseline IOP seen during culture are probably caused by cell fragments and debris from dying cells in the meshwork, ciliary body, and other anterior segment tissues.
The perfusion organ culture model of the anterior segment of the human eye maintains an intraocular pressure (IOP) in the physiologic range for up to 28 days.
1 This model allows experimentation on human eyes not possible in vivo, and has been used in studies by several laboratories over the past 17 years.
1 2 3 4 5 6 7 8 9 10 Despite this widespread usage, few studies have been conducted to investigate or make refinements to the original technique of the culture system itself.
11 12 One puzzling aspect has been that variations of 2 or 3 mm Hg can occur in baseline IOP levels, despite the constant rate of infusion of culture medium. The living eye has known diurnal fluctuations in IOP due to variability in aqueous formation, ranging from 4.5 μL/min during the morning to 1.0 μL/min at night.
13 In contrast, the perfusion culture model uses the mean of the human flow rates, 2.5 μL/min, infused at a constant rate with a microinfusion pump. Despite this constant flow rate, variations in baseline IOP can occur in the culture model. In addition, the initial IOP can be elevated in some cultures during the first several days, after which IOP decreases to baseline.
Changes in pressure during culture have been attributed to either transient showers of cell debris from dying cells or biochemical and metabolic cellular changes as cells adapt to the culture environment.
1 2 6 Because the donor eyes used for culture are retrieved after death, blood flow through the eye and aqueous formation have ceased. Death of some cells before culture is an unavoidable consequence in this situation. These dead cells arise not only in the trabecular meshwork, but also in the ciliary body, iris, and other anterior segment tissues. After the dead cells are shed from their usual position, they ultimately are washed into the trabecular meshwork and could cause the initial elevation of IOP in cultured anterior segments. In addition to the initial cell loss, a slow, ongoing loss of trabecular cells also occurs during culture: 15% by day 7 and 25% by day 28, when compared with freshly fixed, noncultured fellow eyes.
11 The extent to which debris from these dead cells can plug the outflow channels and cause variations in baseline IOP is unknown. In the present study, we examined the causes for variable IOP during culture in more detail.
Investigation of Initial Elevation of IOP.
Fifteen eyes of eight donors with an initial elevation of IOP over 35 mm Hg were studied by either histologic examination or analysis and reinfusion of effluent medium collected while the initial IOP was elevated. Four cultured anterior segments with initial pressures over 35 mm Hg were fixed at 48 hours’ time in culture, while the initial pressures remained elevated, and examined by light and electron microscopy. Two of these anterior segments had fellow eyes with cultured pressures under 30 mm Hg and were examined as controls.
Effluent medium was collected from four eyes during the initial elevation of IOP and examined by light microscopy, looking for evidence of dead cells or cellular debris. Protein levels were analyzed in effluent medium collected during the initial 3 days in 11 eyes with high IOP (>35 mm Hg) and 5 eyes with initial IOP less than 30 mm Hg (mean: 19.8 ± 5.7 mm Hg). Effluent medium was also collected from the same cultures after IOP had lowered to a stable baseline. Stable baseline IOP was considered ≤25 mm Hg with variations of ±3 mm Hg over 24 hours. Medium was frozen at −70°C until analysis. Protein levels were determined with the Bradford method (BioRad, Hercules, CA).
14
To determine whether debris found in the effluent medium could actually cause pressure elevation, effluent medium was collected, centrifuged, and reperfused into eyes once a stable baseline had been reached. This experiment was performed in 11 anterior segments from six pairs of eyes with initial elevation of IOP, and 5 anterior segments from three pairs of eyes with no initial elevation of IOP. Effluent medium from these eyes was collected during the time of initial IOP elevation or the comparable time if no IOP elevation occurred. Medium was centrifuged at 14,000 rpm for 5 minutes and then reinfused into the same eye after baseline IOP had been established, using an anterior chamber exchange followed by perfusion with this “old” medium for 30 hours
(Table 1) . Culture medium was then switched to fresh medium and culture resumed. In 5 of the 11 anterior segments with initial IOP elevation, the effluent was spun twice: first at 14,000 rpm for 5 minutes and then again at 35,000 rpm for 30 minutes
(Table 1) .
To determine whether a protein present in the effluent medium caused the IOP elevation (such a protein would wash out of the eye and meshwork during the initial culture period) the collected effluent medium from 5 of the 11 anterior segments with initial IOP elevation was first heated to 85°C for 10 minutes to heat-denature any proteins and then centrifuged at 14,000 rpm for 5 minutes, before reinfusion into the cultures.
A crossover experimental design was used in these initial IOP elevation experiments, giving sequential experimental infusions to the same anterior segment, making the total number of experimental trials greater than the total number of anterior segments listed in this portion of the study.
In addition to these experimental studies, a review of the past 125 pairs of cultured eyes used in this and other experiments was performed. Note was made of cultures with an IOP higher than 35 mm Hg during the initial time in culture. Relationships with donor age, sex, postmortem time to enucleation, and time to culture were determined and compared between eyes with pressures higher and lower than 35 mm Hg.
Investigation of Variability of Baseline IOP.
Acute loss of a large number of trabecular cells was induced by infusing the toxic compound APMA (p-aminophenylmercuric acetate) into six cultures by anterior chamber exchange at 0.6 mM in either single or sequential doses. After the final dose, DNase (1500 U) was added to both experimental and control anterior segments from four pairs of eyes, while the IOP was still elevated.
Loss of smaller numbers of cells was examined with a dose–response study using cell fragments from monolayer cultured human embryonal kidney cells (HEK293 cells). These cells were harvested and lysed by sonification. Cell fragments from 30,000 cells suspended in culture medium and mixed with 1500 U DNase were added by anterior chamber exchange. This amount of cells is approximately 6% of the total number of trabecular cells, as calculated later. After pressure returned to baseline several days later, fragments from 60,000 cells with DNase were added. Fellow control eyes received anterior chamber exchange with DNase in vehicle only. Anterior segments were fixed either at the time of maximum intraocular elevation after the infusion of the cell fragments or after IOP had returned to baseline.
The number of trabecular cells in the entire meshwork was calculated by using a circumference of 36 mm
15 and 110 trabecular cells per 1-μm-thick section (actual mean ± SD: 110.4 ± 24.5; range: 82–173 cells per 1-μm section.
11 16 Using nuclei as the basis for counting trabecular cells and assuming one nuclei per cell and an average nuclear size of 8 μm (range: 7–10 μm), we estimate that approximately 495,000 trabecular cells are present in the entire meshwork.
A dose–response study of human genomic DNA (Promega, Madison, WI) was performed using doses from 0.26 to 5.10 μg given in single or sequential doses (
Table 1 ; the equivalent of 30,000–600,000 cells). In two pairs of eyes a repeated dose of DNA, previously found to increase IOP in that eye, was given but first digested with 1500 U DNase.
Cell fragments and DNA can both elevate IOP in cultured anterior segments. A dose–response relationship was seen, with larger amounts causing greater changes in outflow facility. A slow, ongoing loss of cells occurs in the meshwork and ciliary body during culture.
11 As these dead cells are washed into the outflow channels, they probably cause the transient variations in baseline IOP seen in this culture model. These small variations in IOP probably represent the cumulative effect of debris in the meshwork as small aqueous pathways become plugged. When enough become plugged to raise IOP, the ongoing constant flow of media probably pushes the debris through the small channels, opening them once again.
12 Loss of larger numbers of cells all at once, as occurred with APMA, results in higher and more acute spikes of IOP. Enrichment of the culture medium with growth factors or other supplements may decrease this ongoing trabecular cell loss. Simple addition of fetal bovine serum did not prevent cell loss in previous experiments.
1 11 In addition, fetal bovine serum is “undefined,” and contains factors not present in aqueous, which could induce or suppress cellular functions or proteins not normally present in trabecular cells.
The initial elevation of IOP is mainly from cell debris in the meshwork. In the postmortem interval between death and culture, the lack of blood flow and aqueous flow cause death of several cell types in the eye. Vascular-dependent tissues are most susceptible, such as ciliary body and iris. Aqueous-dependent tissues, the trabecular meshwork and the cornea, can retain viability for longer periods, but are still subject to postmortem effects. Previous studies have shown that the trabecular meshwork is nonviable in approximately 25% of anterior segment cultures, presumably because of the postmortem condition of the trabecular cells at the initiation of culture.
1 11 Although no significant difference between high and low initial IOP eyes for postmortem time to enucleation or time to culture, we have noted over the past 19 years that eyes placed in culture within 18 hours after death are most successful, with 24 hours the upper limit of reliable viability. Eyes beyond 24 hours have a culture success rate of only approximately 50%, versus the 78% success rate with fresher tissue (published
12 and unpublished observations from our laboratory).
Given this initial load of dead cells in anterior segments, careful removal of non-necessary tissues (iris, lens, choroid, retina) is required when eyes are placed in culture. In addition, multiple rinses of the anterior segment in sterile saline before final placement in the culture dish are necessary to remove loose pigment and debris. We have removed the ciliary body in other experiments, but have found that this causes loss of the uveal meshwork layers and also appears to collapse the remaining meshwork, because of loss of countertraction on the scleral spur. Removal of ciliary processes while leaving the ciliary muscles intact could eliminate a source of dying cells, but requires meticulous dissection and also creates a pool of pigment that can enter and clog the meshwork despite saline rinses.
The reinfusion of effluent medium collected during the initial period of IOP elevation supports the idea that the cause of the pressure elevation is media borne. The finding of cellular debris in the effluent medium and the decrease in IOP-elevating effect after high-speed centrifugation are consistent with this. A significant amount of protein is present in effluent medium during the first 3 days of culture. This comes not only from the trabecular meshwork, but from other tissues throughout the anterior segment. We have found depots of protein in the sclera, cornea, and ciliary body that become depleted with culture time (data not shown). These protein stores probably arise because these tissues are bathed in plasma from their vascular supply during life. Several findings suggest this protein does not raise pressure: Protein levels in effluent medium were similar in eyes with and without elevation of pressure during the initial culture period; heat denaturation did not affect the ability of effluent medium to raise pressure; and finally, higher levels of protein from human serum (2500 μg) and fetal bovine serum (25,000 μg) did not raise pressure in previous experiments.
19
The massive cell loss caused by APMA demonstrates the importance of performing histology on all drug studies in this culture system. Changes in facility may not only be due to a presumed metabolic action of an experimental drug, but could also be due to unplanned cell death caused by the drug. We have noted that several little-considered factors, such as osmolality and pH of solutions, can cause cell death in this system. Dissection and removal of the meshwork for biochemical or molecular analysis should include saving and examining two wedges of tissue, 180° apart, for histologic examination before meshworks are used in these analyses.
All culture models have strengths and limitations that must be understood in interpreting results of experiments. The elevation of IOP found in 31% of cultured anterior segments must be allowed to stabilize, as debris passes through the meshwork, before the cultures can be used. Once the initial debris and elevation of pressure have subsided and baseline pressures are present, cultures with an initial elevation of IOP can be satisfactorily used for experiments. The transient baseline pressure changes that occur in many cultures point out the necessity for the fellow eye to be used as a control eye in experiments, as these spontaneous fluctuations in pressure should not be regarded as caused by an experimental drug or agent. Given histologic verification of the health of the meshwork in each culture and knowing the limitations of the model, perfusion organ culture of the trabecular meshwork continues to have a role in glaucoma research.
Supported in part by National Eye Institute Grant EY07065; Research to Prevent Blindness, Inc.; and the Mayo Foundation, Rochester, Minnesota.
Submitted for publication February 13, 2004; revised May 7, 2004; accepted May 18, 2004.
Disclosure:
C.K. Bahler, None;
M.P. Fautsch, None;
C.R. Hann, None;
D.H. Johnson, None
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked “
advertisement” in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Corresponding author: Douglas H. Johnson, Department of Ophthalmology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905;
johnson.douglas@mayo.edu.
Table 1. Doses and Results of Experimental Studies
Table 1. Doses and Results of Experimental Studies
| n | Experimental Eye | | | Control Eye | | |
| | Baseline | After Infusion (6 h) | Cd/Co | Baseline | After Infusion (6 h) | Cd/Co |
Part 1: Investigation of initial elevation of IOP | | | | | | | |
Media reinfuse | | | | | | | |
Raw media | 6 | 0.15 ± 0.02 | 0.08 ± 0.01 | 0.57* | 0.12 ± 0.02 | 0.15 ± 0.02 | 1.25 |
Heat denatured | 5 | 0.17 ± 0.02 | 0.11 ± 0.01 | 0.68 | 0.18 ± 0.01 | 0.15 ± 0.01 | 0.89 |
High spin | 5 | 0.17 ± 0.01 | 0.14 ± 0.01 | 0.86 | 0.21 ± 0.01 | 0.17 ± 0.01 | 0.83 |
Low initial IOP | 5 | 0.16 ± 0.02 | 0.14 ± 0.02 | 0.89 | 0.20 ± 0.03 | 0.18 ± 0.02 | 0.97 |
Part 2: Investigation of variable baseline IOP | | | | | | | |
Acute cell loss | 6 | 0.15 ± 0.01 | 0.07 ± 0.01 | 0.44* | 0.19 ± 0.05 | 0.23 ± 0.09 | 1.14 |
Cell debris | | | | | | | |
30,000 cells | 6 | 0.17 ± 0.01 | 0.13 ± 0.01 | 0.80, ** | 0.19 ± 0.03 | 0.18 ± 0.02 | 1.02 |
60,000 cells | 7 | 0.17 ± 0.01 | 0.11 ± 0.01 | 0.65, ** | 0.17 ± 0.02 | 0.16 ± 0.02 | 0.98 |
DNA | | | | | | | |
0.26 μg; (≅30,000 cells) | 7 | 0.22 ± 0.07 | 0.15 ± 0.02 | 0.77, ** | 0.21 ± 0.04 | 0.28 ± 0.12 | 1.16 |
1.28 μg | 4 | 0.19 ± 0.02 | 0.11 ± 0.01 | 0.61, ** | 0.21 ± 0.02 | 0.20 ± 0.02 | 0.95 |
2.56 μg | 2 | 0.19 ± 0.04 | 0.11 ± 0.01 | 0.61 | 0.20 ± 0.01 | 0.19 ± 0.04 | 0.97 |
5.12 μg | 3 | 0.33 ± 0.17 | 0.14 ± 0.06 | 0.46, ** | 0.26 ± 0.01 | 0.25 ± 0.01 | 1.07 |
Johnson DH, Tschumper RC. Human trabecular meshwork organ culture: a new method. Invest Ophthalmol Vis Sci
. 1987;28:945–953.
[PubMed]Pang IH, McCartney MD, Steely HT, Clark AF. Human ocular perfusion organ culture: a versatile ex vivo model for glaucoma research. J Glaucoma
. 2000;9:468–479.
[CrossRef] [PubMed]Erickson-Lamy K. The perfused human ocular anterior segment as a model for aqueous outflow physiology. J Glaucoma
. 1992;1:44–53.
[CrossRef] Clark AF, Wilson K, deKater AW, Allingham RR, McCartney MD. Dexamethasone-induced ocular hypertension in perfusion-cultured human eyes. Invest Ophthalmol Vis Sci
. 1995;36:478–489.
[PubMed]Goldwich A, Ethier CR, Chan DW, Tamm ER. Perfusion with the olfactomedin domain of myocilin does not affect outflow facility. Invest Ophthalmol Vis Sci
. 2003;44:1953–1961.
[CrossRef] [PubMed]Bradley JMB, Vranka J, Colvis CM, et al. Effect of Matrix metalloproteases activity on outflow in perfused human organ culture. Invest Ophthalmol Vis Sci
. 1998;39:2649–2658.
[PubMed]Borras T, Rowlette LL, Tamm ER, Gottanka J, Epstein DL. Effects of elevated intraocular pressure on outflow facility and TIGR/MYOC expression in perfused human anterior segments. Invest Ophthalmol Vis Sci
. 2002;43:33–40.
[PubMed]Nguyen TD, Chen P, Huang WD, Chen H, Johnson DH, Polansky JR. Gene structure and properties of TIGR, an olfactomedin-related glycoprotein cloned from glucocorticoid-induced trabecular meshwork cells. J Biol Chem
. 1998;273:6341–6350.
[CrossRef] [PubMed]Santas AJ, Bahler C, Peterson JA, et al. Effect of heparin II domain of fibronectin on aqueous outflow in cultured anterior segments of human eyes. Invest Ophthalmol Vis Sci
. 2003;44:4796–4804.
[CrossRef] [PubMed]Dijkstra BG, Ruijer JM, Hoyng PF. Outflow characteristics of isolated anterior segments of human eyes. Invest Ophthalmol Vis Sci
. 1996;37:2015–2021.
[PubMed]Johnson DH, Tschumper RC. The effect of organ culture on human trabecular meshwork. Exp Eye Res
. 1989;49:113–127.
[CrossRef] [PubMed]Johnson DH. Human trabecular meshwork cell survival is dependent on perfusion rate. Invest Ophthalmol Vis Sci
. 1996;37:1204–1208.
[PubMed]Brubaker RF. Flow of aqueous humor in humans. Invest Ophthalmol Vis Sci
. 1991;32:3145–3166.
[PubMed]Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem
. 1976;72:248–254.
[CrossRef] [PubMed]Hogan MJ, Alvarado JA, Weddell JE. Histology of the Human Eye. 1971;138. WB Saunders Philadelphia.
Tschumper RC, Johnson DH. Trabecular meshwork cellularity: Differences between fellow eyes. Invest Ophthalmol Vis Sci
. 1990;31:1327–1331.
[PubMed]Epstein DL, Rowlette LL, Roberts BC. Acto-myosin drug effects and aqueous outflow function. Invest Ophthalmol Vis Sci
. 1999;40:74–81.
[PubMed]Colton T. Statistics in Medicine. 1974; Little, Brown Boston.
Fautsch MP, Bahler CK, Jewison DJ, Johnson DH. Recombinant TIGR/MYOC increases outflow resistance in the human anterior segment. Invest Ophthalmol Vis Sci
. 2000;41:4163–4168.
[PubMed]